Kevin Kalinsky, MD (IMAGE) SWOG Caption Kevin Kalinsky, MD, is the study lead for the RxPONDER breast cancer clinical trial designed and managed by SWOG Cancer Research Network and funded by the National Cancer Institute. Credit Emory University Usage Restrictions Please credit Emory License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.